Preparation and Characterization of Prednisolone Acetate Microemulsion for Ophthalmic Use

Autor: Reem Alfaris, Khalid K Al-Kinani

Publikováno v: مجلة كلية الطب, Vol 65, Iss 3 (2023)

Background: Prednisolone acetate is an ester form of prednisolone. It is used topically as an ophthalmic suspension to treat many inflammatory ocular conditions, where its absorption from suspension is highly variable and has poor dose accuracy. Ob

Externí odkaz: https://doaj.org/article/693cd6e5a34f4f0aba72aba68f03b225

Access to mifepristone, misoprostol, and contraceptive medicines in eight countries in the Eastern Mediterranean Region: descriptive analyses of country-level assessments.

Autor: Afifi M; World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, Egypt. afifim@who.int., Hemachandra N; World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, Egypt., Sikandar Q; World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, Egypt., Hajjeh R; World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, Egypt., Loi UR; Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Geneva, Switzerland., Läser L; Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Geneva, Switzerland., Qato D; Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Geneva, Switzerland., Abdul ZS; Ministry of Public Health, Kabul, Afghanistan., Chikvaidze P; World Health Organization, Afghanistan Country Office, Kabul, Afghanistan., Abbas RAR; Ministry of Health, Baghdad, Iraq., Al-Kinani K; University of Baghdad, Baghdad, Iraq., Hasan H; World Health Organization, Iraq Country Office, Baghdad, Iraq., El-Kak F; American University in Beirut, Beirut, Lebanon., Rady A; Lebanon Country Office, World Health Organization, Beirut, Lebanon., Brngali O; Ministry of Health, Tripoli, Libya., Hashem M; World Health Organization, Libya Country Office, Tripoli, Libya., Bezad R; Mohammed V University of Rabat, Rabat, Morocco., Amine C; Cheikh Zaid Hospital, Rabat, Morocco., Hafid H; World Health Organization, Morocco Country Office, Rabat, Morocco., Afzal S; Ministry of National Health Services Regulations and Coordination, Islamabad, Pakistan., Zaidi R; Ministry of National Health Services Regulations and Coordination, Islamabad, Pakistan., Thom E; Pakistan Country Office, World Health Organization, Islamabad, Pakistan., Uzma Q; Pakistan Country Office, World Health Organization, Islamabad, Pakistan., Al-Masri H; Palestinian Ministry of Health, Ramallah, Palestine., Qamar ZA; Palestinian Ministry of Health, Ramallah, Palestine., Ghanem B; World Health Organization Office for West Bank and Gaza, Jerusalem, Palestine., Ward IA; World Health Organization Office for West Bank and Gaza, Jerusalem, Palestine., Shaar AN; An-Najah National University, West Bank, Palestine., Farah U; Ministry of Health and Human Services, Mogadishu, Somalia., Mohamed YO; Ministry of Health and Human Services, Mogadishu, Somalia., Umar AU; Somalia Country Office, World Health Organization, Mogadishu, Somalia., Eladawy M; World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, Egypt.

Publikováno v: Reproductive health [Reprod Health] 2024 Jun 04; Vol. 20 (Suppl 1), pp. 192. Date of Electronic Publication: 2024 Jun 04.